Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b7a3d9ece0f46f57ff17f509fdffbbf |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbd97f49f55d582cd45909175ef15dae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9aa15d6904e4a4549ed7f69ac6d0a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca42237798550e3f961f0004f341c4d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af657e5c5f36a137ed2231f418adcb68 |
publicationDate |
2022-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022223015-A1 |
titleOfInvention |
Sirna targeting 17β-hydroxysteroid dehydrogenase type 13 and sirna conjugate |
abstract |
An siRNA targeting 17β-hydroxysteroid dehydrogenase type 13 and a siRNA conjugate. Also disclosed are a pharmaceutical composition, cell or kit containing the siRNA, and a method for using the siRNA for the treatment and/or prevention of subjects suffering from HSD17B13-related disorders (such as chronic fibroinflammatory liver disease). |
priorityDate |
2021-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |